Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
29.16 USD | -0.51% | -2.89% | -9.38% |
30/04 | Harmony Biosciences Acquires Epygenix Therapeutics; Shares Rise | MT |
30/04 | Transcript : Harmony Biosciences Holdings, Inc., Q1 2024 Earnings Call, Apr 30, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.38% | 166.46Cr | |
+32.05% | 69TCr | |
+29.39% | 59TCr | |
-1.46% | 37TCr | |
+19.95% | 33TCr | |
+7.29% | 29TCr | |
+14.25% | 24TCr | |
-3.03% | 21TCr | |
+10.02% | 21TCr | |
+8.38% | 17TCr |
- Stock Market
- Equities
- HRMY Stock
- News Harmony Biosciences Holdings, Inc.
- Goldman Sachs Downgrades Harmony Biosciences Holdings to Sell From Neutral, Cuts Price Target to $31 From $40